COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination
In the frame of the coronavirus disease 2019 (COVID-19) pandemic, recent reports on SARS-CoV-2 potential neuroinvasion placed neurologists on increased alertness in order to assess early neurological manifestations and their potentially prognostic value for the COVID-19 disease. Moreover, the manage...
Main Authors: | Marina Kleopatra Boziki, Alexios-Fotios A. Mentis, Maria Shumilina, Gleb Makshakov, Evgeniy Evdoshenko, Nikolaos Grigoriadis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/10/6/345 |
Similar Items
-
Primary antiphospholipid syndrome progressing to systemic lupus erythematosus: a case report
by: Rocco Manganelli, et al.
Published: (2013-04-01) -
ANTIPHOSPHOLIPID SYNDROME: DIAGNOSIS AND CLINICAL MANIFESTATIONS (A LECTURE)
by: Tat’yana M Reshetnyak
Published: (2014-03-01) -
Development of Systemic Autoimmune Diseases in Healthy Subjects Persistently Positive for Antiphospholipid Antibodies: Long-Term Follow-Up Study
by: Fulvia Ceccarelli, et al.
Published: (2022-08-01) -
An Antiphospholipid Antibody Profile as a Biomarker for Thrombophilia in Systemic Lupus Erythematosus
by: Ryo Hisada, et al.
Published: (2023-03-01) -
Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients
by: Natasa Stanisavljevic, et al.
Published: (2022-10-01)